Evidence map›Paper›PMID 22956999›Full record

ArticlePloS one2012

Complex structure of engineered modular domains defining molecular interaction between ICAM-1 and integrin LFA-1.

Sungkwon Kang, Chae Un Kim, Xiaoling Gu, Roisin M Owens, Sarah J van Rijn, Vanissra Boonyaleepun, Yuxin Mao, Timothy A Springer, Moonsoo M Jin

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sungkwon KangDepartment of Biomedical Engineering, Cornell University, Ithaca, New York, United States of America.
Chae Un Kim
Xiaoling Gu
Roisin M Owens
Sarah J van Rijn
Vanissra Boonyaleepun
Yuxin Mao
Timothy A Springer
Moonsoo M Jin
Cornell University · USHarvard University · US

Funding

Overall (pp. 40-62)P41GM103485 · NIGMS · CORNELL UNIVERSITY · PI CERIONE, RICHARD A. · 2012 to 2018
$15.5M
Developing ICAM-1 for rhinovirus therapeuticsR21AI079532 · NIAID · CORNELL UNIVERSITY · PI JIN, MOONSOO M. · 2008 to 2010
$615k
NIAID NIH HHS R21 AI079532NIGMS NIH HHS GM103485NIGMS NIH HHS P41 GM103485
6 · The paper itself

Abstract

Intermolecular contacts between integrin LFA-1 (α(L)β(2)) and ICAM-1 derive solely from the integrin α(L) I domain and the first domain (D1) of ICAM-1. This study presents a crystal structure of the engineered complex of the α(L) I domain and ICAM-1 D1. Previously, we engineered the I domain for high affinity by point mutations that were identified by a directed evolution approach. In order to examine α(L) I domain allostery between the C-terminal α7-helix (allosteric site) and the metal-ion dependent adhesion site (active site), we have chosen a high affinity variant without mutations directly influencing either the position of the α7-helix or the active sites. In our crystal, the α(L) I domain was found to have a high affinity conformation to D1 with its α7-helix displaced downward away from the binding interface, recapitulating a current understanding of the allostery in the I domain and its linkage to neighboring domains of integrins in signaling. To enable soluble D1 of ICAM-1 to fold on its own, we also engineered D1 to be functional by mutations, which were found to be those that would convert hydrogen bond networks in the solvent-excluded core into vdW contacts. The backbone structure of the β-sandwich fold and the epitope for I domain binding of the engineered D1 were essentially identical to those of wild-type D1. Most deviations in engineered D1 were found in the loops at the N-terminal region that interacts with human rhinovirus (HRV). Structural deviation found in engineered D1 was overall in agreement with the function of engineered D1 observed previously, i.e., full capacity binding to α(L) I domain but reduced interaction with HRV.

Indexed as

Allosteric RegulationAmino Acid SequenceAmino Acid SubstitutionCrystallography, X-RayDirected Molecular EvolutionHumansHydrogen BondingIntercellular Adhesion Molecule-1Lymphocyte Function-Associated Antigen-1Models, MolecularMolecular Sequence DataMutagenesis, Site-DirectedProtein BindingProtein Interaction Domains and MotifsProtein Structure, SecondaryStructural Homology, ProteinICAM1 protein, humanIntercellular Adhesion Molecule-1Lymphocyte Function-Associated Antigen-1

Identifiers

PMID22956999
PMCPMC3431320
OpenAlexW2144331361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.